Methotrexate 25 mg / mL Injection 40 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 16729-0277-35 |
|---|---|
| Product NDC | 16729-0277 |
| Generic Drug Name | Methotrexate |
| Brand Name | Methotrexate |
| Manufacturer | Accord Healthcare, Inc. |
| Strength | 25 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intra-Arterial; Intramuscular; Intrathecal; Intravenous |
| Package Quantity | 1 Vial |
| Package Description | 1 VIAL in 1 CARTON (16729-277-35) / 40 mL in 1 VIAL |
| Active Ingredients | Methotrexate |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Methotrexate 25 mg / mL Injection is tracked under NDC 16729-0277-35 and rolls up into product family 16729-0277. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Vial.
- Manufacturer: Accord Healthcare, Inc..
- Dosage form: Injection.
- Family size: 3 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 4 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative HubMethotrexate 25 mg / mL Injection 40 mL Vial5 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Documented shortage history shows this NDC appearing in shortage-related listings three times since 2012, a repeat pattern that suggests elevated future supply risk.
Drug Shortage Index family
View Methotrexate in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Methotrexate.Source: Public FDA drug shortage records accessed through FDA-owned openFDA drug shortages queries.
This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Methotrexate 25 mg / mL Injection 40 mL, NDC 16729-0277-35, is a Accord Healthcare, Inc. 25 mg / mL injection presentation packaged as 1 Vial. Current public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 16729-0277-35
- Digits-only NDC 11: 16729027735
- Possible 10-digit display format: 16729-277-35 (1672927735)
Helpful product links
- Search by brand name: Methotrexate
- NDC 11: 16729-0277-35
- Product family NDC: 16729-0277
- Compare related presentations: Methotrexate 25 mg / mL Injection 10 mL, Methotrexate 25 mg / mL Injection 2 mL
- VA classification code: AN300
- VA classification code description: ANTINEOPLASTICS,ANTIMETABOLITES
- CMOP ID: M0289
- VUID: 4002745